2025 Zoonotic Disease Treatment Industry Trends Report: Long-Term Outlook Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Zoonotic Disease Treatment Market Size By 2025?
The market size for the treatment of zoonotic diseases has seen robust growth in recent years, rising from $39.71 billion in 2024 to an anticipated $42.64 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 7.4%. Factors contributing to this growth in the historical period include the rise of significant zoonotic outbreaks, effects of urbanization and habitat intrusion, the implementation of a one health approach, enhanced surveillance measures and reporting systems, impacts of globalization, increased travel activities, and the escalating levels of public awareness and education.

How Big Is the Zoonotic Disease Treatment Market Size Expected to Grow by 2029?
In the coming years, it is predicted that the zoonotic disease treatment market size will experience robust growth, reaching $55.92 billion by 2029 with a compound annual growth rate (CAGR) of 7.0%. Factors such as environmental changes and climate shift, government and international financial support, advancements in medical technology, regulatory backing and streamlined approval procedures, and combined research and development initiatives contribute to this growth in the stipulated period. Key trends for the forecast period encompass the production of broad-spectrum antivirals, fortification of global health systems, advancements in diagnostic technologies, expansion of vaccine development platforms, and an emphasis on preventive measures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Key Market Drivers Powering Zoonotic Disease Treatment Market Expansion and Growth?
The growth of the zoonotic disease treatment market is predicted to be driven by the heightened demand for animal proteins. Derived from sources like meat, dairy, eggs, and fish, animal proteins provide all essential amino acids that humans require. Factors such as a growing global population, increased income levels, urbanization, and heightened awareness about the health benefits of animal-based foods contribute to this increased demand. Zoonotic disease treatments provide strategies for managing diseases linked to animal proteins, understanding transmission routes, creating potent therapies, and enforcing preventive steps to mitigate risks to public health. As pointed out by a report in July 2023, released by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization, it is estimated that the global meat consumption in the US-based agricultural commodity market will grow at an annual rate of 0.1%. The uptick is largely driven by escalating demands from middle and lower-income nations, wherein poultry might contribute to roughly half of meat production growth by 2032. Hence, the rise in the demand for animal proteins is fueling the growth of the zoonotic disease treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Zoonotic Disease Treatment Market?
Leading businesses in the zoonotic disease treatment market are emphasizing on increasing their investment in treating zoonotic diseases to upgrade their diagnostic abilities and enhance treatment methodologies. This involves creation of innovative diagnostic tools, including PCR kits, for swift spotting of zoonotic pathogens and executing specific therapeutic interventions. For example, in October 2023, BioPerfectus, a Chinese biotech firm with a specialization in diagnostic solutions, introduced thirteen fresh additions to its Zoonotic Infectious Diseases Total PCR Solution. This extension is intended to strengthen its diagnostics for zoonotic diseases, which are responsible for over 60% of acknowledged infectious diseases and 75% of newly discovered infections. The plan is meant to boost readiness and reaction to health security, especially as climatic changes propagate infectious diseases to virgin territories. Through these additional products, the firm is looking forward to facilitating expeditious diagnosis and superior management of zoonotic infections, underscoring the need for pre-emptive public health actions.

What Are the Emerging Segments in the Zoonotic Disease Treatment Market?
The zoonotic disease treatment market covered in this report is segmented -

1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types
2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:
1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment
3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis
5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment
6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Who Are the Global Leaders in the Zoonotic Disease Treatment Market?
Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

Which are the Top Profitable Regional Markets for the Zoonotic Disease Treatment Industry?
North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15965

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.